Dr. Sarita Rani Jaiswal

Program Director

18 years of experience

Hemato-Oncologist

MBBS, DNB, MD, Fellowship

Dharamshila Narayana Superspeciality Hospital, New Delhi

English, Hindi

Consultation Fee ₹ 600

Book an Appointment

About Dr. Sarita Rani Jaiswal

Dr. Sarita Rani Jaiswal is a renowned hematologist and an expert in haploidentical BMT.
She has more than 18 years of experience and has developed novel procedures for stem cell transplantation.
Over the past years, Dr. Sarita has performed approximately 200 haploidentical stem cell transplants with outstanding outcomes.
She specializes in providing treatments like allogeneic and autologous bone marrow transplant.
Dr. Jaiswal has effectively treated patients with thalassemia and sickle cell anemia.
Her educational qualifications include an MBBS degree from MGM Medical College, Jamshedpur, in 1996. She then completed her residency at MGM Medical College, Jamshedpur, in 1997, gaining essential clinical experience and honing his medical skills.
In 2006, Dr. Jaiswal undertook a senior residency at Jitendra Narayana Hospital, where she further developed his expertise in patient care and medical practice.
She obtained her Diplomate of National Board (DNB) in Family Medicine from Kothari Medical Centre, Kolkata, in 2008, specializing in comprehensive healthcare for families.
An MD from DY Patil University in 2011 furthered her knowledge and expertise in the medical field.
In 2013, Dr. Jaiswal pursued a Hematology and Bone Marrow Transplantation (BMT) fellowship at Apollo Gleneagle Hospital, Kolkata, specializing in advanced hematological treatments.
Dr. Jaiswal also completed a fellowship in Haplo NK Cell Biology at IRCCS AOU San Martino Hospital, Genova, in 2013, focusing on innovative cell biology research.
She underwent a fellowship in Bone Marrow Transplantation under the mentorship of Dr. Suparno Chakrabarti in India and a fellowship at the University of Parma, Italy, under the guidance of Prof. Franco Aversa, contributing to her global medical perspective.
She has authored over 100 research papers and articles in well-known journals in the field of hematology.
She has been an active member of the American Society of Blood and Marrow Transplantation (ASBMT), the American Society of Hematology, and the European Hematology Association (EHA).
She actively educates patients about cancer, stem cell transplantation, and other related diseases and treatments through interactive YouTube videos.

Education

MBBS, MGM Medical College, Jamshedpur, 1996
DNB in Family Medicine, Kothari Medical Centre, Kolkata, 2008
MD, DY Patil University, 2011
Fellowship in Hematology and BMT, Apollo Gleneagle Hospital, Kolkata, 2013
Fellowship in Haplo NK Cell Biology, IRCCS AOU San Martino Hospital, Genova, 2013
Fellowship in BMT under Dr Suparno Chakrabarti, India
Fellowship at the University of Parma under Prof Franco Aversa, Italy

Training & Certificates

Trained in TCR alpha beta depleted Haploidentical BMT under Prof Aversa

Associations/Membership

American Society of Blood and Marrow Transplantation (ASBMT)
American Society of Hematology
European Hematology Association (EHA)
Asia Pacific Hematology Consortium (APHCON)

Paper Published

Dr. Sarita Rani Jaiswal has authored over 100 scientific research articles in well-known and highly regarded journals. Some of her most cited and acknowledged papers are:

Jaiswal, S. R., Zaman, S., Chakrabarti, A., Sen, S., Mukherjee, S., Bhargava, S., Chakrabarti, S., et al. (2016). Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning and early prophylactic granulocyte colony-stimulating factor–mobilized donor lymphocyte infusions. Biology of Blood and Marrow Transplantation, 22(10), 1867-1873.
Jaiswal, S. R., Chakrabarti, A., Chatterjee, S., Bhargava, S., Ray, K., O'Donnell, P., & Chakrabarti, S. (2016). Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan-based conditioning. Biology of Blood and Marrow Transplantation, 22(3), 499–504.
Jaiswal, S. R., Zaman, S., Nedunchezhian, M., Chakrabarti, A., Bhakuni, P., Ahmed, M., Chakrabarti, S., et al. (2017). CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: a pilot study. Cytotherapy, 19(4), 531-542.
Jaiswal, S. R., Bhakuni, P., Zaman, S., Bansal, S., Bharadwaj, P., Bhargava, S., & Chakrabarti, S. (2017). T-cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia. Transplant Immunology, 43, 54-59.